Distinct Dosage Compensations of Ploidy-sensitive and -insensitive X Chromosome Genes During Development and in Diseases
Overview
Affiliations
The active X chromosome in mammals is upregulated to balance its dosage to autosomes during evolution. However, it is elusive why the known dosage compensation machinery showed uneven and small influence on X genes. Here, based on >20,000 transcriptomes, we identified two X gene groups (ploidy-sensitive [PSX] and ploidy-insensitive [PIX]), showing distinct but evolutionarily conserved dosage compensations (termed XAR). We demonstrated that XAR-PIX was downregulated whereas XAR-PSX upregulated at both RNA and protein levels across cancer types, in contrast with their trends during stem cell differentiation. XAR-PIX, but not XAR-PSX, was lower and correlated with autoantibodies and inflammation in patients of lupus, suggesting that insufficient dosage of PIX genes contribute to lupus pathogenesis. We further identified and experimentally validated two XAR regulators, and . Collectively, we provided insights into X dosage compensation in mammals and demonstrated different regulation of PSX and PIX and their pathophysiological roles in human diseases.
Sex Disparities in P53 Regulation and Functions: Novel Insights for Personalized Cancer Therapies.
Cardano M, Buscemi G, Zannini L Cells. 2025; 14(5).
PMID: 40072091 PMC: 11898824. DOI: 10.3390/cells14050363.
Ndou L, Chambuso R, Algar U, Boutall A, Goldberg P, Ramesar R Biomedicines. 2025; 12(12.
PMID: 39767815 PMC: 11672899. DOI: 10.3390/biomedicines12122906.
Sex-biased genome-editing effects of CRISPR-Cas9 across cancer cells dependent on p53 status.
Guo M, Xiong Y iScience. 2023; 26(9):107529.
PMID: 37636042 PMC: 10448110. DOI: 10.1016/j.isci.2023.107529.